Induction of chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian topoisomerase I.

[1]  H. Andersson,et al.  The production of chromosomal alterations in human lymphocytes by drugs known to interfere with the activity of DNA topoisomerase II. I. m-AMSA. , 1989, Carcinogenesis.

[2]  S. Crooke,et al.  Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. , 1987, Cancer research.

[3]  L. Dillehay,et al.  Cell cycle dependence of sister chromatid exchange induction by DNA topoisomerase II inhibitors in Chinese hamster V79 cells. , 1987, Cancer research.

[4]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[5]  Y. Pommier,et al.  Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells. , 1985, Cancer research.

[6]  J. Wang,et al.  Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Kihlman Ba,et al.  Potentiation of chromosomal alterations by inhibitors of DNA repair. , 1984 .

[8]  L. Liu,et al.  DNA topoisomerases--enzymes that catalyse the breaking and rejoining of DNA. , 1983, CRC critical reviews in biochemistry.

[9]  Y. Pommier,et al.  The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei. , 1982, Biochemical and biophysical research communications.

[10]  S. Weisbrod.  Properties of active nucleosomes as revealed by HMG 14 and 17 chromatography. , 1982, Nucleic acids research.

[11]  F. Palitti,et al.  Comparison of the frequencies of SCEs induced by chemical mutagens in bone-marrow, spleen and spermatogonial cells of mice. , 1982, Mutation research.

[12]  K. Kohn,et al.  Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. , 1981, Biochemistry.

[13]  A. Natarajan,et al.  Use of the 5-bromodeoxyuridine-labelling technique for exploring mechanisms involved in the formation of chromosomal aberrations. , 1980, Mutation research.

[14]  H. Andersson,et al.  Use of the 5-bromodeoxyuridine-labelling technique for exploring mechanisms involved in the formation of chromosomal aberrations I. G2 experiments with root-tips of Vicia faba , 1978 .

[15]  W. Wray,et al.  Scanning-electron microscopy of chromosome aberrations. , 1978, Mutation research.

[16]  R. Adamson,et al.  Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. , 1971, Journal of the National Cancer Institute.